$BIIB Headlines Biogen results crush consensus
Post# of 144503
Posted On: 08/11/2014 11:02:12 AM
$BIIB Headlines
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 3:54 p.m. Aug. 8, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: NTAP, BIIB, USB 12:44 p.m. Aug. 8, 2014 - TheStreet.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
Sanofi: Confronting Lantus Patent Expiry With More Efficient Successor Toujeo 11:59 a.m. Aug. 7, 2014 - Seeking Alpha
TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis, Reimbursed in Alberta 10:00 a.m. Aug. 7, 2014 - CNW Group
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Why Investors Should Closely Watch Celgene 3:53 p.m. Aug. 6, 2014 - benzinga.com
Five Large Caps With Earnings Growth Of 25% Or More 11:46 a.m. Aug. 5, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MA, UNH, BIIB 11:14 a.m. Aug. 4, 2014 - TheStreet.com
Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog 9:20 a.m. Aug. 4, 2014 - Zacks.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Biotech Gets A Lift On Popular Drug, Strong Pipeline 6:13 p.m. Aug. 1, 2014 - Investors Business Daily
Stock Market News for August 01, 2014 - Market News 10:10 a.m. Aug. 1, 2014 - Zacks.com
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Increased Earnings Estimates Seen for Biogen Idec (BIIB): Can It Move Higher? - Tale of the Tape 8:57 a.m. July 31, 2014 - Zacks.com
Biotech Valuations Are Low Not Stretched. Here's Why. 8:35 a.m. July 31, 2014 - TheStreet.com
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Today - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 3:54 p.m. Aug. 8, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: NTAP, BIIB, USB 12:44 p.m. Aug. 8, 2014 - TheStreet.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
Sanofi: Confronting Lantus Patent Expiry With More Efficient Successor Toujeo 11:59 a.m. Aug. 7, 2014 - Seeking Alpha
TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis, Reimbursed in Alberta 10:00 a.m. Aug. 7, 2014 - CNW Group
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Why Investors Should Closely Watch Celgene 3:53 p.m. Aug. 6, 2014 - benzinga.com
Five Large Caps With Earnings Growth Of 25% Or More 11:46 a.m. Aug. 5, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MA, UNH, BIIB 11:14 a.m. Aug. 4, 2014 - TheStreet.com
Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog 9:20 a.m. Aug. 4, 2014 - Zacks.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Biotech Gets A Lift On Popular Drug, Strong Pipeline 6:13 p.m. Aug. 1, 2014 - Investors Business Daily
Stock Market News for August 01, 2014 - Market News 10:10 a.m. Aug. 1, 2014 - Zacks.com
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Increased Earnings Estimates Seen for Biogen Idec (BIIB): Can It Move Higher? - Tale of the Tape 8:57 a.m. July 31, 2014 - Zacks.com
Biotech Valuations Are Low Not Stretched. Here's Why. 8:35 a.m. July 31, 2014 - TheStreet.com
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Today - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼